After the transaction, Enright Patrick G's stake was reported as 32,442 shares of Jazz Pharmaceuticals Plc stock.
As noted on January 16, 2013, Enright Patrick G's sale was done indirectly through "By Longitude Capital Associates, L.P." over 2 transactions on January 15, 2013. The share price ranged from $56.72 to $56.72 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, Enright Patrick G has sold a total of 23,228 shares of Jazz Pharmaceuticals Plc, proceeds from the sale totaled $1,317,534. Over the same time period, Enright Patrick G has purchased no shares of Jazz Pharmaceuticals Plc stock.
Let's take a quick, high-level look at insider trading at Jazz Pharmaceuticals Plc over the past 12 months. A total of 11,297,666 shares of Jazz Pharmaceuticals Plc stock was sold by insiders, totaling $560,118,812. Over the same time 12 month time period, no shares of Jazz Pharmaceuticals Plc were purchased by company insiders.
To view the complete SEC Filing: Jazz Pharmaceuticals Plc Form 4 (Insider Trading) SEC Filing
